Lantana Projects
Wide Adoption of Rapid Molecular Detection of Antimicrobial Resistance Markers for Use with Blood Cultures
Virgie Fields, Amy Webb, and Marissa McMeen co-authored the Wide adoption of rapid molecular detection of antimicrobial resistance markers for use with blood cultures: implications for national surveillance of antimicrobial resistance publication with CDC. In this study, we summarize the adoption of molecular testing for AR among US acute care hospitals and discuss the potential…
Read MoreThe Impact of a Nationwide Blood Culture Bottle Shortage in 2024 on Healthcare Facilities in the United States
Lantana Public Health Analysts Clay Bryant and Marissa McMeen co-authored a study in the journal Clinical Infectious Diseases assessing national blood culture bottle shortage. This work highlights the importance of collaboration, innovation, and real-time data collection in strengthening preparedness and healthcare system resilience.
Read MoreSupplemental findings of the 2023 National Blood Collection and Utilization Survey
Rebecca Lien co-authored the Supplemental findings of the 2023 National Blood Collection and Utilization Survey publication, to estimate the blood collection and utilization within the United States.
Read MoreHave we reached a new baseline for blood collection and transfusion in the United States? National Blood Collection and Utilization Survey, 2023
This publication discusses data from the National Blood Collection and Utilization Survey (NBCUS) suggesting a stabilization in blood collections and transfusions following years of decline, co-authored by Rebecca Lien. Data from the 2023 NBCUS were analyzed to further understand national trends in US blood availability.
Read MorePatient safety as a measure of resilience in US hospitals: central line-associated bloodstream infections, July 2020 through June 2021
Mathew Sapiano co-authored a Centers for Disease Control and Prevention (CDC) study on the impact that stressors associated with the COVID-19 pandemic had on patient safety, as measured by central line-associated bloodstream infections (CLABSIs) reported to the Centers for Disease Control and Prevention’s National Healthcare Safety Network.
Read MoreCDC MMWR Study—Coverage with Influenza, RSV, and COVID-19 Vaccines Among Nursing Home Residents — NHSN, November 2024
Lantana Public Health Analysts Heather Dubendris and Brynn Lape-Newman co-authored a study published in the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report (MMWR) assessing COVID-19, influenza, and respiratory syncytial virus (RSV) vaccination coverage for nursing home residents during the 2024-25 respiratory virus season. Learn more about the elevated risks for nursing home…
Read MoreCoverage with Influenza, Respiratory Syncytial Virus, and COVID-19 Vaccines Among Nursing Home Residents — National Healthcare Safety Network, United States, November 2024
Heather Dubendris of Lantana Consulting Group co-authored a recent publication highlighting low early-season COVID-19, flu, and RSV vaccination rates among nursing home residents—one of the most vulnerable populations. Strengthening coverage remains essential to protecting those at highest risk.
Read MoreInfluenza and COVID-19 Vaccination Coverage Among Health Care Personnel — National Healthcare Safety Network, United States, 2023–24 Respiratory Virus Season
Heather Dubendris co-authored on this publication regarding CDC/NHSN data showing a major gap in influenza and COVID-19 vaccination coverage among health care personnel, especially in nursing homes. Strengthening vaccination uptake is key to protecting frontline teams and maintaining resilient care systems.
Read MoreThe NHSN’s Digital Quality Measures: CDC’s Automated Surveillance for Patient Safety
Lantana is proud to announce a new publication: “The NHSN’s digital quality measures: CDC’s automated surveillance for patient safety,” in the Journal of the American Medical Informatics Association (JAMIA). This article provides a comprehensive overview of our contributions to National Healthcare Safety Network (NHSN), highlighting our longstanding commitment to improving patient safety.
Read MoreCDC MMWR Study—Influenza, RSV, and Updated COVID-19 Vaccine Coverage Among Nursing Home Residents for December 2023
Heather Dubendris co-authored a Centers for Disease Control and Prevention (CDC) study for the Morbidity and Mortality Weekly Report (MMWR) that assessed the coverage of the COVID-19, influenza, and respiratory syncytial virus (RSV) vaccines among nursing home residents during the 2023-24 respiratory virus season.
Read MoreCDC Study Reveals Disparities in COVID-19 Vaccination Coverage
Emily Haanschoten and Heather Dubendris co-authored the study, Disparities in COVID-19 Vaccination Status Among Long-Term Care Facility Residents — United States, October 31, 2022–May 7, 2023 published in Morbidity and Mortality Weekly Report (MMWR). Disparities in COVID-19 vaccination coverage among Long Term Care residents based on geography and racial demographics were identified by the CDC’s…
Read MoreVital Signs: Health Disparities in Hemodialysis-Associated Staphylococcus aureus Bloodstream Infections — United States, 2017–2020
Selective and Cascade Reporting of Antimicrobial Susceptibility Testing Results and Its Impact on Antimicrobial Resistance Surveillance—National Healthcare Safety Network, April 2020 to March 2021
Laboratory-Confirmed COVID-19 Case Incidence Rates Among Residents in Nursing Homes by Up-to-Date Vaccination Status — United States, October 10, 2022–January 8, 2023
Surveillance of COVID-19 Vaccination in Nursing Homes, United States, December 2020–July 2021
National Healthcare Safety Network 2018 Baseline Neonatal Standardized Antimicrobial Administration Ratios
In 2019, the Centers for Disease Control and Prevention developed neonatal-specific (Standardized Antimicrobial Administration Ratios SAARs), a set of risk-adjusted antimicrobial use metrics that hospitals participating in the National Healthcare Safety Network’s (NHSN’s) antimicrobial use surveillance can use in their antibiotic stewardship programs (ASPs). This article outlines the methods and results of developing those SAARs.…
Read MoreAxe the Fax: Save Money and Lower Your Climate Footprint
Increasing Voluntary Public Health Reporting to the NHSN Antimicrobial Use Option
National Healthcare Safety Network Standardized Antimicrobial Administration Ratios (SAARs): A Progress Report and Risk Modeling Update Using 2017 Data
US Hydroxychloroquine, Chloroquine, and Azithromycin Outpatient Prescription Trends, October 2019 Through March 2020
Nadine Shehab, Chief Scientist, co-authored this CDC report which quantifies changes in outpatient prescriptions of hydroxychloroquine, chloroquine, and azithromycin during the COVID-19 pandemic.
Read More